Franco-Canadian start-up Angany claims to be “gaining momentum” for its plant-based immunotherapy platform. The firm aims to leverage the immunogenicity and safety profile of its

Avianax and LEVOYA entered an agreement to develop business opportunities in the veterinary industry, with an initial focus in concluding a licensing agreement with an

LOOKING AHEAD… Most of the year we dedicate our efforts to helping our clients build their future business. But as we get ready to celebrate